Loading...
Antibiotic Resistance And Payer Access Challenges Will Eventually Support A Cautious Long-Term Recovery
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-76.7%7D
-15.4%1Y
-76.7%7D
-15.4%You can edit this narrative until Dec 12 4:20 AM. Then, changes will post as Updates.